Browsing Tag
generics
7 posts
Glenmark’s U.S. launch of Leucovorin Calcium for Injection: A strategic play in the generics arena
Find out how Glenmark Pharmaceuticals’ latest U.S. launch could reshape hospital generics in 2025. Will this move boost its global strategy?
Viatris (Nasdaq: VTRS) exits Biocon Biologics with $815m deal as biosimilars reentry accelerates
Viatris unlocks $815M from Biocon Biologics exit and regains biosimilars access. Find out how this reshapes its 2026 global pharma strategy.
Biocon goes all-in on biosimilars with $5.5bn Biocon Biologics merger and Viatris exit
Biocon to merge Biocon Biologics in $5.5B deal with full ownership via share swap and cash. Find out what it means for investors and global biosimilar strategy.
Dr. Reddy’s company profile: Respiratory, generics, and global drug pipeline in 2025
Explore Dr. Reddy’s FY25 financials, drug pipeline, and global expansion strategy—see why it’s gaining attention in pharma investment circles.
Pharmaceutical shake-up: Mallinckrodt and Endo to merge in blockbuster $6.7bn deal
Mallinckrodt plc and Endo, Inc. have announced a definitive agreement to merge in a stock and cash transaction…
Zydus Lifesciences announces Punit Patel as new CEO for Americas operations
Global lifesciences firm, Zydus Lifesciences Limited, recently declared the appointment of Punit Patel as the President and Chief…
Biocon launches generic Tacrolimus in U.S.: A gamechanger in transplant care
Find out how Biocon’s launch of generic Tacrolimus in the U.S. marks a strategic leap in affordable transplant care and global generic market expansion.